Business Description
Onconetix Inc
NAICS : 541713
SIC : 2834
ISIN : US09610B1089
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -0.6 | |||||
Debt-to-Equity | -0.43 | |||||
Debt-to-EBITDA | -0.3 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -4.95 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -144.5 | |||||
3-Year EPS without NRI Growth Rate | -96.2 | |||||
3-Year FCF Growth Rate | -71.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 11.35 | |||||
9-Day RSI | 19.42 | |||||
14-Day RSI | 27.67 | |||||
6-1 Month Momentum % | -29.5 | |||||
12-1 Month Momentum % | -78.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.1 | |||||
Quick Ratio | 0.09 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 229.87 | |||||
Days Sales Outstanding | 47.74 | |||||
Days Payable | 1176.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.5 | |||||
Shareholder Yield % | -0.66 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 23.79 | |||||
Operating Margin % | -1200.41 | |||||
Net Margin % | -3631.17 | |||||
FCF Margin % | -1084.25 | |||||
ROA % | -94.99 | |||||
ROIC % | -28.38 | |||||
3-Year ROIIC % | -17.74 | |||||
ROC (Joel Greenblatt) % | -39919.35 | |||||
ROCE % | -136.32 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.44 | |||||
EV-to-EBIT | -0.89 | |||||
EV-to-EBITDA | -0.9 | |||||
EV-to-Revenue | 31.52 | |||||
EV-to-FCF | -2.91 | |||||
Earnings Yield (Greenblatt) % | -112.36 | |||||
FCF Yield % | -49.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Onconetix Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.352 | ||
EPS (TTM) (€) | -100.385 | ||
Beta | 0 | ||
Volatility % | 133.65 | ||
14-Day RSI | 27.67 | ||
14-Day ATR (€) | 0.054948 | ||
20-Day SMA (€) | 2.82 | ||
12-1 Month Momentum % | -78.48 | ||
52-Week Range (€) | 2.74 - 13.904 | ||
Shares Outstanding (Mil) | 8.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Onconetix Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Onconetix Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Onconetix Inc Frequently Asked Questions
What is Onconetix Inc(FRA:J4T0)'s stock price today?
When is next earnings date of Onconetix Inc(FRA:J4T0)?
Does Onconetix Inc(FRA:J4T0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |